CREDIT SUISSE AG 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:57 pm Purchase | 2021-12-31 | 13G | Addex Therapeutics Ltd ADXN | CREDIT SUISSE AG | 93,830 4.950% | 118 (+0.13%) | Filing |
| 2021-02-12 3:53 pm Purchase | 2020-12-31 | 13G | Addex Therapeutics Ltd ADXN | CREDIT SUISSE AG | 93,712 5.710% | 93,712 (New Position) | Filing |